and the survival times of cancer patients who die with their disease present (Boag, 1949) , especially those with cancers of the cervix (Mould & Boag, 1975) and bNote: Only 9% of all recorded symptom durations were greater than 2 years and therefore have not been used in this analysis.
Very little information on symptom durations of cancer patients has been published in the literature and not even a table of typical symptom duration ranges for different cancer sites can be found. Nevertheless data on symptom duration if available can provide useful information when studying the natural history of the disease and when investigating possible correlations between symptom duration and posttreatment survival (Mould, 1985) . However, when cancer registries changed from manual to computer systems, many which previously stored symptom durations discontinued this practice. In addition, during system changeovers some registries actually destroyed the relevant record cards from the earlier registration years. These factors make it extremely difficult in the United Kingdom to now The lognormal distribution was chosen for study since it is known to represent many positively skewed frequency distributions in nature, such as infant mortality rates (Schrek & Lipson, 1941) , response times for different drugs (Gaddum, 1945; Lea, 1945) and the survival times of cancer patients who die with their disease present (Boag, 1949) , especially those with cancers of the cervix (Mould & Boag, 1975) and cancers of the head and neck (Mould et al., 1976 Model fitting using chi-squared tests were accomplished using software written for use with the Hewlett-Packard 86B microprocessor based Westminster Hospital Cancer Registry (Mould, 1982) and the results are shown in Table II (Mould & Boag, 1975 ) although values in the range S = 0.45 to 0.50 are better for cancer of the head and neck (Mould et al., 1976) . These models refer to cancer follow-up after treatment, whereas the data under discussion in this paper relate to the time before treatment. In this case (Table II) , the optimum values of S are in the range 0.50 to 0.65, which represents a different family of lognormal curves than those describing survival after treatment.
For 30 of the 37 site groups the lognormal was found to be a good fit for a range of values of S differing by at least 0.10, and in nine of these 30 groups, differing by at least 0.20 (Table II) . Over this range of values of S for a given site group the chi-squared estimate of M usually remained reasonably stable. It is therefore suggested that the lognormal distribution can be used in practice to provide a first estimate of the frequency distribution of cancer symptom durations in the range 0-2 years, particularly since no alternative method exists.
